Insurance payment for artificial intelligence technology: Methods used by a stroke artificial intelligence system and strategies to qualify for the new technology add-on payment
Restricted accessReview articleFirst published online June, 2022
Insurance payment for artificial intelligence technology: Methods used by a stroke artificial intelligence system and strategies to qualify for the new technology add-on payment
The first ever insurance reimbursement for an artificial intelligence (AI) system, which expedites triage of acute stroke, occurred in 2020 when the Centers for Medicare and Medicaid Services (CMS) granted approval for a New Technology Add-on Payment (NTAP). Key aspects of the AI system that led to its approval by the CMS included its unique mechanism of action, use of robotic process automation, and clear linkage of the system’s output to clinical outcomes. The specific strategies employed encompass a first-case scenario of proving reimbursable value for improved stroke outcomes using AI. Given the rapid change in utilization of AI technology in stroke care, we describe the economic drivers of stroke AI systems in healthcare, focusing on concepts of reimbursement for value added by AI to the stroke care system. This report reviews (1) the successful approach used by the first NTAP-approved AI system, (2) economic variables in insurance reimbursement for AI, and (3) resultant strategies that may be utilized to facilitate qualification for NTAP reimbursement, which may be adopted by other AI systems used in stroke care.
ChenMMGoldingLPNicolaGN. Who will pay for AI?Radiol Artif Intell2021; 3: e210030. DOI: 10.1148/ryai.2021210030.
2.
KunzWGHuninkMGAlmekhlafiMA, et al.Public health and cost consequences of time delays to thrombectomy for acute ischemic stroke. Neurology2020; 95: e2465–e2475. DOI: 10.1212/WNL.0000000000010867.
3.
Centers for Medicare & Medicaid Services (CMS) HHS. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and final policy changes and fiscal year 2021 rates; quality reporting and medicare and medicaid promoting interoperability programs requirements for eligible hospitals and critical access hospitals. In: Service CfMM, (ed.). CMS-1735-F. Washington, DC: Federal Register2020, pp.58432–59107.
4.
ClydeATBockstedtLFarkasJA, et al.Experience with medicare’s new technology add-on payment program. Health Aff (Millwood)2008; 27: 1632–1641. DOI: 10.1377/hlthaff.27.6.1632.
5.
ManzCRBekelmanJEDoshiJA. The changing characteristics of technologies covered by medicare’s new technology add-on payment program. JAMA Netw Open2020; 3: e2012569. DOI: 10.1001/jamanetworkopen.2020.12569.
MurrayNMUnberathMHagerGD, et al.Artificial intelligence to diagnose ischemic stroke and identify large vessel occlusions: a systematic review. J Neurointerv Surg2020; 12: 156–164. DOI: 10.1136/neurintsurg-2019-015135.
8.
AlgraPRMorozovSRanschaertER. Artificial Intelligence in Medical Imaging: Opportunities, Applications and Risks. 1st ed.London, UK: Springer International Publishing: Imprint: Springer, 2019, p. 1. online resource (XV, 373 pages 104 illustrations, 381 illustrations in color.
9.
MaddoxTMRumsfeldJSPaynePRO. Questions for artificial intelligence in health care. JAMA2019; 321: 31–32. DOI: 10.1001/jama.2018.18932.
10.
Administration SS. Payment to Hospitals for Inpatient Hospital Services. Section 1886(d)(5)(K). Woodlawn, MD: SSA, 2020.
11.
Regulations CoF. Title 42 - Public Health, Chapter Iv - Centers for Medicare & Medicaid Services, Department of Health and Human Services, Subchapter B - Medicare Program, Part 412 - Prospective Payment Systems for Inpatient Hospital Services, Subpart F - Payments for Outlier Cases, Special Treatment Payment for New Technology, and Payment Adjustment for Certain Replaced Devices, Subjgroup - Additional Special Payment for Certain New Technology, Section 412.87 - Additional Payment for New Medical Services And Technologies: General Provisions. Hague, Netherlands: International criminal court, 2010.
12.
DanzonPMDrummondMFTowseA, et al. Objectives, budgets, thresholds, and opportunity costs-a health economics approach: an ispor special task force report [4]. Value in Health2018; 21: 140–145.
13.
AronssonMPerssonJBlomstrandC, et al.Cost-effectiveness of endovascular thrombectomy in patients with acute ischemic stroke. Neurology2016; 86: 1053–1059. DOI: 10.1212/WNL.0000000000002439.
14.
Services CfMM. Medicare Program; Medicare Coverage of Innovative Technology and Definition of Reasonable and Necessary. Woodlawn, MD: CMS; 2021.
15.
MoreyJRKatanaMLiL, et al.Adoption and trends in the medicare new technology add-on payment program. J Gen Intern Med2021; 36: 2174–2176. DOI: 10.1007/s11606-020-05930-y.
16.
HassanAE. New technology add-on payment (NTAP) for Viz LVO: a win for stroke care. J Neurointerv Surg2021; 13: 406–408. DOI: 10.1136/neurintsurg-2020-016897.
17.
JudsonTJDhruvaSSRedbergRF. Evaluation of technologies approved for supplemental payments in the United States. BMJ2019; 365: l2190. DOI: 10.1136/bmj.l2190.
van der AalstWMPBichlerM.HeinzlA.Robotic process automation. Business & Information Systems Engineering2018; 60: 269–272.
20.
MurrellK. Operator variability and its industrial consequences. International Journal of Production Research1961; 1: 39–55.
21.
Letourneau-GuillonLCamirandDGuilbertF, et al.Artificial intelligence applications for workflow, process optimization and predictive analytics. Neuroimaging Clin N Am2020; 30: e1–e15. DOI: 10.1016/j.nic.2020.08.008.
22.
PowersWJRabinsteinAAAckersonT, et al.2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke2018; 49: e46–e110. DOI: 10.1161/STR.0000000000000158.
23.
GoyalMJadhavAPBonafeA, et al.Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: results from the swift prime randomized controlled trial. Radiology2016; 279: 888–897. DOI: 10.1148/radiol.2016160204.
24.
CollaboratorsGBDN. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol2019; 18: 459–480. DOI: 10.1016/S1474-4422(18)30499-X.
25.
GerkeSSternADMinssenT. Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries. NPJ Digit Med2020; 3: 94. DOI: 10.1038/s41746-020-0306-7.
26.
BindraP. The Core Elements of Value in Healthcare. Chicago, IL: Health Administration Press, 2018.
27.
AbramoffMDLavinPTBirchM, et al.Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med2018; 1: 39. DOI: 10.1038/s41746-018-0040-6.
